Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany.
Department of Psychiatry and Psychotherapy, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; Berlin Institute of Health, Anna-Louisa-Karsch-Straße 2, 10178 Berlin, Germany.
Schizophr Res. 2018 May;195:190-196. doi: 10.1016/j.schres.2017.09.030. Epub 2017 Sep 27.
The rs1625579 variant near the microRNA-137 (MIR137) gene is one of the best-supported schizophrenia variants in genome-wide association studies (GWAS), and microRNA-137 functionally regulates other GWAS identified schizophrenia risk variants. Schizophrenia patients with the MIR137 rs1625579 risk genotype (homozygous for the schizophrenia risk variant) also have aberrant brain structure. It is unclear if the effect of MIR137 among schizophrenia patients is due to potential epistasis with genetic risk for schizophrenia or other factors of the disorder. Here, we investigated the effect of MIR137 genotype on white matter fractional anisotropy (FA), cortical thickness (CT), and surface area (SA) in a sample comprising healthy control subjects, and individuals with familial risk for psychosis (first-degree relatives of patients with schizophrenia or bipolar disorder; N=426). In voxel-wise analyses of FA, we observed a significant genotype-by-group interaction (P<0.05). The familial risk group with risk genotype had lower FA (P<0.05), but there was no genetic association in controls. In vertex-wise analyses of SA, we also observed a significant genotype-by-group interaction (P<0.05). Relatives with MIR137 risk genotype had lower SA, however the risk genotype was associated with higher SA in the controls (all P<0.05). These results show that MIR137 risk genotype is associated with lower FA in psychosis relatives that is similar to previous imaging-genetics findings in patients with schizophrenia. Furthermore, MIR137 genotype may also be a risk factor in a subclinical population with wide reductions in white matter FA and cortical SA.
rs1625579 变体位于 microRNA-137(MIR137)基因附近,是全基因组关联研究(GWAS)中支持精神分裂症的最佳变体之一,并且 microRNA-137 功能上调节其他 GWAS 确定的精神分裂症风险变体。携带 MIR137 rs1625579 风险基因型(精神分裂症风险变体的纯合子)的精神分裂症患者也存在异常的大脑结构。尚不清楚 MIR137 在精神分裂症患者中的作用是否归因于与精神分裂症遗传风险的潜在上位效应,还是该疾病的其他因素。在这里,我们研究了 MIR137 基因型对包括健康对照者和精神病风险个体(精神分裂症或双相情感障碍患者的一级亲属;N=426)在内的样本中的白质各向异性分数(FA)、皮质厚度(CT)和表面积(SA)的影响。在 FA 的体素分析中,我们观察到基因型与组的显著相互作用(P<0.05)。具有风险基因型的家族风险组 FA 较低(P<0.05),但在对照组中没有遗传关联。在 SA 的顶点分析中,我们还观察到基因型与组的显著相互作用(P<0.05)。携带 MIR137 风险基因型的亲属 SA 较低,但是风险基因型与对照组的高 SA 相关(均 P<0.05)。这些结果表明,MIR137 风险基因型与精神病亲属的 FA 降低有关,这与先前精神分裂症患者的影像学遗传学发现相似。此外,MIR137 基因型也可能是一个亚临床人群的风险因素,这些人群的白质 FA 和皮质 SA 广泛减少。